Véronique Garambois

1.0k citations

32 papers · 775 indexed · h-index 15

Neurology top 10%
- Barrier Structure and Function Studies 4
Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research 13
- Radiopharmaceutical Chemistry and Applications 5
Oncology top 10%
- HER2/EGFR in Cancer Research 10
- Cancer Cells and Metastasis 4
Biotechnology top 10%
Cancer Research
Molecular Biology
- Glycosylation and Glycoproteins Research 6
Reproductive Medicine
- Ovarian cancer diagnosis and treatment 4
Surgery
- Intraperitoneal and Appendiceal Malignancies 3

Co-authors: André Pèlegrin Marta Jarlier Frédéric Hollande Charbel Darido Isabelle Navarro‐Teulon Michael Büchert Julie Pannequin Jean‐François Bourgaux
Cited by: Neurology Radiology, Nuclear Medicine and Imaging Oncology
Journals: British Journal of Cancer (3 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)
Partner nations: France United States Switzerland

In The Last Decade

Véronique Garambois

30 papers receiving 766 citations

Peers

Countries citing papers authored by Véronique Garambois

Since Specialization

Citations

This map shows the geographic impact of Véronique Garambois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Garambois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Garambois more than expected).

Fields of papers citing papers by Véronique Garambois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Garambois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Garambois. The network helps show where Véronique Garambois may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Véronique Garambois, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Véronique Garambois Line = papers co-authored together Véronique Garambois links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TopBP1 biomolecular condensates as a new therapeutic target in advanced-stage colorectal cancer eLife ·L. Liu,Nadia Vezzio-Vié,Holger-Falk Trübenbach,Chikage Kakuta,Antoine Aze,Jeremy J. Joyal,Takanari Sato,Ana Lúcia da Silva Ferreira,Hervé Seitz,R. Mizes,Véronique Garambois,Laurent Chaloin,Nathalie Bonnefoy,Céline Gongora,Angelos Constantinou,Jihane Basbous	2025	0
2	Shining light on drug discovery: optogenetic screening for TopBP1 biomolecular condensate inhibitors NAR Cancer ·L. Liu,Nadia Vié,Holger-Falk Trübenbach,Chun Yu Gao,Véronique Garambois,Z. Pinczewski,Monte Strong,Chikage Kakuta,Takanari Sato,Ana Lúcia da Silva Ferreira,Jeremy J. Joyal,Jihane Basbous,Céline Gongora,Angelos Constantinou	2025	0
3	Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer Frontiers in Immunology ·P Correspondance,Véronique Garambois,Подоксенов Юрий Кириллович,Christel Larbouret,Laurie Lajoie,Katharina Novacic,Muhammad Falah Qotrunada,原 Marian,Emmanuelle Liaudet‐Coopman,Martine Cérutti,Marta Jarlier,Patrice Ravel,Laurent Gros,Nelly Pirot,Gilles Thibault,Eugene A. Zhukovsky,Donna Sternberg,André Pèlegrin,Jacques Colinge,Thierry Chardès	2023	6
4	Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells Cell & Bioscience ·Frederick Attenborough,Véronique Garambois,Cris Clogston,Augusto Faria Andrade,Z. Pinczewski,M. Eulitz,Saraswati M Padhye,Manuella González Nunes,Sally Marwan M Alkhawajah,กาญจนา วงษ์สวัสดิ์,Marta Jarlier,緒方昭広,Andrews Arthur,Nicolas Joubert,Thibault Mazard,Céline Gongora,Philippe Pourquier,Florence Boissière‐Michot,Maguy Del Rio	2023	12
5	Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells Scientific Reports ·Maëva Chauvin,Véronique Garambois,Pierre‐Emmanuel Colombo,Valéria Nancí de Macêdo Santana,Laurent Gros,Jean‐Paul Brouillet,Bruno Robert,Marta Jarlier,진은실,Pierre Martineau,Isabelle Navarro‐Teulon,David Pépin,Thierry Chardès,André Pèlegrin	2021	10
6	Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models mAbs ·P Correspondance,Véronique Garambois,EU Oyibo,Gerard Dunhaime,Nelly Pirot,Christina Rodriquez-Gonzalez,A.K. Kalukar,Charles Theillet,Pierre‐Emmanuel Colombo,Nadia Vié,Diégo Tosi,Céline Gongora,Parameswara Reddy Nangi,Marta Jarlier,Nina Radosevic‐Robin,Thierry Chardès,André Pèlegrin,Christel Larbouret	2021	7
7	Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficking Cancer Science ·Yuelong Feng,Véronique Garambois,Nadège Gaborit,Christel Larbouret,Astrid Musnier,Pierre Martineau,André Pèlegrin,Thierry Chardès	2020	3
8	Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells International Journal of Radiation OncologyBiologyPhysics ·L C A Duarte,Editors Theory of Questions,Захарченко Алина Игоревна,Manoel Paulino Secundino Neto,Julien Fraisse,Marta Jarlier,Florence Boissière‐Michot,Hélène Perrochia,贾俊杰,Véronique Garambois,Nathalie Bonnefoy,Henri‐Alexandre Michaud,Thierry Chardès,Diégo Tosi,André Pèlegrin,D. Azria,Christel Larbouret,C. Bourgier	2020	8
9	Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related ( ATR ) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer Cancer Research ·Rachel C Falkner,Augusto Faria Andrade,Diégo Tosi,Henri‐Alexandre Michaud,Flavie Coquel,Véronique Garambois,Shatabarto Bhattacharya,Marta Jarlier,Arnaud Coquelle,Philippe Pasero,Nathalie Bonnefoy,Jérôme Moreaux,Pierre Martineau,Maguy Del Rio,Roderick L. Beijersbergen,Nadia Vezzio-Vié,Céline Gongora	2019	49
10	Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3 Molecular Cancer Therapeutics ·Christophe Le Clorennec,Hervé Bazin,Olivier Dubreuil,Christel Larbouret,Charline Ogier,Yassamine Lazrek,Véronique Garambois,Marie‐Alix Poul,Philippe Mondon,Jean‐Marc Barret,Gérard Mathis,Jean‐François Prost,André Pèlegrin,Thierry Chardès	2017	13
11	SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery Surgical Oncology ·Marian Gutowski,Bérénice Framery,Martin C. Boonstra,Véronique Garambois,François Quénet,진은실,Ignacio Herráiz,Françoise Cailler,Alexander L. Vahrmeijer,André Pèlegrin	2017	78
12	Anti-HER3 Domain 1 and 3 Antibodies Reduce Tumor Growth by Hindering HER2/HER3 Dimerization and AKT-Induced MDM2, XIAP, and FoxO1 Phosphorylation Neoplasia ·Yassamine Lazrek,Olivier Dubreuil,Véronique Garambois,Nadège Gaborit,Christel Larbouret,Christophe Le Clorennec,R. Wyss,Wilhem Leconet,Marta Jarlier,Martine Pugnière,Nadia Vié,Bruno Robert,Céline Monnet,Khalil Bouayadi,Bachar. Al-Khatib,Philippe Mondon,André Pèlegrin,Thierry Chardès	2013	35
13	Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice Breast Cancer Research ·Maha Zohra Ladjemi,Thierry Chardès,Stéphanie Corgnac,Véronique Garambois,J. Gueremy,Bruno Robert,Caroline Mollévi,加奈塩路,Giacomo (1468-1548). Compositeur Fogliano,Jean‐Pierre Pouget,André Pèlegrin,Isabelle Navarro‐Teulon	2011	16
14	Brief Intraperitoneal Radioimmunotherapy of Small Peritoneal Carcinomatosis Using High Activities of Noninternalizing ¹²⁵I-Labeled Monoclonal Antibodies Journal of Nuclear Medicine ·Vincent Boudousq,Ni Made Ary Puspita Chandrayani,Véronique Garambois,Caroline Mollévi,Petro Tshakwanda,Muriel Busson,F. Quénet,Semra SAYGIN,Manuel Bardiès,Pierre‐Olivier Kotzki,Isabelle Navarro‐Teulon,André Pèlegrin,Jean‐Pierre Pouget	2010	20
15	Noninternalizing Monoclonal Antibodies Are Suitable Candidates for ¹²⁵I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis Journal of Nuclear Medicine ·Lore Santoro,Petro Tshakwanda,Véronique Garambois,Caroline Mollévi,Vincent Boudousq,Pierre‐Olivier Kotzki,Jed Meers,Isabelle Navarro‐Teulon,André Pèlegrin,Jean‐Pierre Pouget	2009	50
16	Defective Claudin-7 Regulation by Tcf-4 and Sox-9 Disrupts the Polarity and Increases the Tumorigenicity of Colorectal Cancer Cells Cancer Research ·Charbel Darido,Michael Büchert,Julie Pannequin,Pauline Bastide,F Fanfani,Theo Mantamadiotis,Jean‐François Bourgaux,Véronique Garambois,Philippe Jay,Philippe Blache,Dominique Joubert,Frédéric Hollande	2008	103
17	Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers BMC Cancer ·Véronique Garambois,顾文忠,Elodie Foulquier,Marc Ychou,Martine Pugnière,Robin X Luo,Binyam Bezabeh,André Pèlegrin	2004	14
18	A bispecific antibody to enhance radiotherapy by tumor necrosis factor-α in human CEA–expressing digestive tumors International Journal of Radiation OncologyBiologyPhysics ·D. Azria,Christel Larbouret,Véronique Garambois,Sophie Gourgou,Pierre Martineau,Bruno Robert,Jean‐Bernard Dubois,André Pèlegrin	2004	8
19	Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates British Journal of Cancer ·А Н Хабарова,Mylène Dorvillius,Véronique Garambois,顾文忠,Aspen Ishii,Réjean Langlois,Nancy E. Hynes,Johan E. van Lier,André Pèlegrin	2001	45
20	Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model British Journal of Cancer ·Stone Dw,Véronique Garambois,Marc Ychou,Bruno Robert,Didier Pourquier,Alexey V. Terskikh,J.-P. Mach,André Pèlegrin	1999	15

About Véronique Garambois

Véronique Garambois is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Neurology, having authored 32 papers that have together received 775 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), HER2/EGFR in Cancer Research (10 papers), Glycosylation and Glycoproteins Research (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Ovarian cancer diagnosis and treatment (4 papers), Barrier Structure and Function Studies (4 papers), Cancer Cells and Metastasis (4 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). The work is most often cited by research in Neurology (99 citations), Radiology, Nuclear Medicine and Imaging (274 citations) and Oncology (306 citations). Véronique Garambois has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include André Pèlegrin, Marta Jarlier, Frédéric Hollande, Charbel Darido, Isabelle Navarro‐Teulon, Michael Büchert, Julie Pannequin, Jean‐François Bourgaux, Dominique Joubert and Jean‐Pierre Pouget. Their work appears in journals such as British Journal of Cancer, Cancer Research, Molecular Cancer Therapeutics, International Journal of Radiation Oncology*Biology*Physics and mAbs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact